Groundbreaking AHEAD study recruiting participants ages 55 and older
WAI Director Cynthia Carlsson, MD, MS, leads the AHEAD study.
Shaping a future free from Alzheimer's disease
WAI Director Cynthia Carlsson, MD, MS, leads the AHEAD study.
Thank you NBC15 for featuring the guide and Dr. Mora Pinzon's contributions.
Art Walaszek, MD, public health leader for WAI, was a guest on WPR to discuss the Alzheimer's disease drug aducanumab and its approval by the FDA.
On June 7, the U.S. Food and Drug Administration (FDA) approved the drug aducanumab for the treatment of Alzheimer’s disease. Read a breakdown on what this means for people living with Alzheimer's disease and family caregivers.
Thank you MKE Lifestyle for a feature article about WAI Regional Milwaukee Office and their work addressing Alzheimer's disease and dementia in the Milwaukee community.
Watch a recording from COVID-19 and Brain Health: Advancing Equity for Caregivers and Community event
Wisconsin Alzheimer's Institute (WAI) is excited to welcome Sarah Klein in her new role as WAI administrator.
Harris joined the program to discuss health disparities and dementia and strategies for change.
The 7th annual Breaking The Silence event welcomed more than 200 attendees on April 15, meeting for the first time virtually.
The Clinical Trails on Alzheimer's Disease (CTAD) conference is November 9 - 12, 2021